Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare carcinoma of the stomach resembling squamous cell carcinomas arising elsewhere in the body.
Biomarker and diagnostic research for gastric squamous cell carcinoma has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered. Interventions under study include drug therapy, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE2, 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.
128 publications have been identified in PubMed for gastric squamous cell carcinoma. Kisho has analyzed 100 by research type. Research spans Review / Meta-Analysis (23%), Case Report / Case Series (22%), and Diagnostic / Biomarker (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 23 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 8:52 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
23%
Patient case studies | 22 | 22% |
Testing and diagnosis research | 17 | 17% |
Disease patterns and progression | 16 | 16% |
Laboratory research | 10 | 10% |
Clinical study results | 8 | 8% |
New treatment approaches | 3 | 3% |
Other research | 1 | 1% |
Masdefiol Garriga A (2026). [PMID: 41185520](https://pubmed.ncbi.nlm.nih.gov/41185520/). *Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc*. [Case Report / Case Series]
Bruss DM (2026). [PMID: 31751103](https://pubmed.ncbi.nlm.nih.gov/31751103/). *Unknown Journal*. [Clinical Trial Publication]
Shah MA (2026). [PMID: 41747202](https://pubmed.ncbi.nlm.nih.gov/41747202/). *J Clin Oncol*. [Review / Meta-Analysis]
Attaelmanan GA (2026). [PMID: 41710851](https://pubmed.ncbi.nlm.nih.gov/41710851/). *Cureus*. [Diagnostic / Biomarker]
Yin X (2026). [PMID: 42190826](https://pubmed.ncbi.nlm.nih.gov/42190826/). *Environ Res*. [Epidemiology / Natural History]
Dunneram Y (2026). [PMID: 41748939](https://pubmed.ncbi.nlm.nih.gov/41748939/). *Br J Cancer*. [Diagnostic / Biomarker]
Yu S (2026). [PMID: 41719041](https://pubmed.ncbi.nlm.nih.gov/41719041/). *JAMA Netw Open*. [Epidemiology / Natural History]
Kurokawa Y (2026). [PMID: 41707650](https://pubmed.ncbi.nlm.nih.gov/41707650/). *Cell Rep Med*. [Diagnostic / Biomarker]
Jia K (2026). [PMID: 41526899](https://pubmed.ncbi.nlm.nih.gov/41526899/). *BMC Med*. [Basic Science / Preclinical]
Dong W (2025). [PMID: 41333217](https://pubmed.ncbi.nlm.nih.gov/41333217/). *Frontiers in oncology*. [Case Report / Case Series]